Biopharma | April 16, 2026
Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
Subscribe To Our Newsletter & Stay Updated
